You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 9, September 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Feature
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Immunology
 •Immunologic Disorders
 •Surgery, Other
 •Kidney Transplantation
 •Oncology, Other
 •Computed Tomography
 •Magnetic Resonance Imaging
 •Alert me on articles by topic

Image of the Month—Diagnosis

Arch Surg. 2003;138:1026.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Answer: Obtain a Biopsy Specimen of the Hepatic Mass

Figure 1. Computed tomographic scan of the liver.


 
Figure appears in full text version.
Figure 1.


Figure 2. Magnetic resonance imaging of the liver.


 
Figure appears in full text version.
Figure 2.


The computed tomographic and magnetic resonance images demonstrated a 6.6-cm lesion of the medial and lateral segments in the left lobe of the liver, peripheral biliary ductal dilatation in both lobes, and obstruction of the common hepatic duct. A biopsy of this lesion was diagnostic of malignant B-cell lymphoma and was positive by in situ hybridization for the Epstein-Barr virus. Serologic analyses confirmed posttransplantation infection by the Epstein-Barr virus. Immunosuppression was discontinued, temporary biliary stenting via endoscopic retrograde cholangiopancreatography was accomplished, and chemotherapy with cyclophosphamide, adriamycin, rituximab, and prednisone was initiated. Five months later, the mass resolved, renal and hepatic function were preserved (serum creatinine, 1.6 mg/dL [141.4 µmol/L]); total bilirubin, 0.4 mg/dL [6.84 µmol/L]), and low-dose immunosuppression has been reinstituted with cyclosporine microemulsion and prednisone.

Posttransplantation lymphoproliferative . . . [Full Text of this Article]


RELATED ARTICLE

Image of the Month—Quiz Case
Amy L. Friedman, Marc I. Lorber, and Dennis Cooper
Arch Surg. 2003;138(9):1025.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.